Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
29%
OVERLAP
BY WEIGHT
BY WEIGHT
5
# OF OVERLAPPING HOLDINGS
OZEM
21
HOLDINGS
26%
ALSO IN MEDX
MEDX
28
HOLDINGS
18%
ALSO IN OZEM
SECTOR DRIFT (OZEM minus MEDX)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in OZEM |
Weight in MEDX |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 16.3% | 16.4% | 16.3% |
|
PFIZER INC | 4.1% | 4.0% | 4.0% |
 |
ASTRAZENECA PLC-SPONS ADR | 3.4% | 5.5% | 3.4% |
|
AMGEN INC | 3.2% | 5.9% | 3.2% |
|
REGENERON PHARMACEUTICALS | 2.5% | 2.4% | 2.4% |
OZEM Overweight Relative to MEDX
 |
NOVO-NORDISK A/S-SPONS ADR | 18.2% |
 |
ROCHE HOLDING LTD | 5.2% |
|
ZEALAND PHARMA A/S | 4.8% |
 |
CHUGAI PHARMACEUTICAL CO LTD | 4.6% |
|
VIKING THERAPEUTICS, INC. | 4.3% |
 |
INNOVENT BIOLOGICS, INC. | 4.0% |
 |
HANMI PHARM CO LTD | 3.1% |
|
TERNS PHARMACEUTICALS, INC. | 2.6% |
|
SCHOLAR ROCK HOLDING CORP. | 2.2% |
|
GILEAD SCIENCES INC | 2.0% |
OZEM Underweight Relative to MEDX
|
ABBVIE INC | -8.8% |
|
NOVARTIS AG-ADR | -7.3% |
|
ALNYLAM PHARMACEUTICALS INC | -5.9% |
|
BRISTOL-MYERS SQUIBB CO | -5.2% |
|
JOHNSON & JOHNSON | -4.8% |
 |
ALKERMES PLC | -4.2% |
|
MERCK & CO. INC. | -3.4% |
|
CRISPR THERAPEUTICS AG | -3.2% |
|
IONIS PHARMACEUTICALS, INC. | -3.1% |
|
GLAXOSMITHKLINE PLC-SPON ADR | -2.7% |